CRWE Wallstreet

_______________________________________

FREE Daily Stock Alerts From CRWEWallStreet.com

_______________________________________

ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, today announced the presentation of encouraging initial clinical findings with SAR3419 at the American Society of Hematology (ASH) 51st Annual Meeting and Exposition. Among the findings reported were responses to SAR3419 - administered as a single agent - among patients with B-cell non-Hodgkin’s lymphoma that is refractory to treatment with rituximab (Rituxan(R)).

Power3 Medical Products, Inc. (OTCBB: PWRM), announced that the company made significant advances in the technology for their BC-SeraPro serum protein based blood test for diagnosis of early stage breast cancer, as disclosed in recent filings of three pending US utility patent applications.
Web Site: http://www.Power3Medical.com

Stericycle, Inc. (NASDAQ:SRCL), announced today that it had completed its pending acquisition of MedServe, Inc., which is now a wholly-owned subsidiary of Stericycle’s. The transaction closed on Friday, December 4, following our receipt of clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (”HSR”) on Monday, November 30, 2009.

Leo Motors, Inc. (LEOM.PK) has several proprietary designs for new electric vehicles for various uses including taxis; fleet operations such as police, mail delivery, and resorts; as well as a unique electric motor cycle. Leo Motors is also developing a revolutionary multi-motor system as well as a new type of refuelable zinc air fuel cell.
Web Site: http://www.leomotors.com

Forest Laboratories, Inc. (NYSE: FRX), an international manufacturer and marketer of pharmaceutical products, today announced that it will host an analysts meeting on Thursday, January 7, 2010 to review its late-stage product development pipeline. The meeting will feature product and therapeutic area presentations by senior leadership from the Forest Research Institute, Inc., the Company’s research and development arm, and senior corporate executives, with emphasis placed on the Company’s late-stage product opportunities.

************Advertisement************

************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEWallStreet publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEWallStreet.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and has received an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and diseminate news and $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Crown Equity Holdings Inc (CRWE.OB)anticipate being compensated $5,000 dollars from a third party for 30 days advertising services for Leo Motors, Inc. (LEOM.PK).

The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.